| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/25/2010 | US7723369 Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors |
| 05/25/2010 | US7723368 Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase |
| 05/25/2010 | US7723367 Amino-tetrazoles analogues and methods of use |
| 05/25/2010 | US7723366 Cardiovascular disorders; antidiabetic agents; anticancer agents |
| 05/25/2010 | US7723365 Mitotic kinesin inhibitors |
| 05/25/2010 | US7723362 for controlling acarina |
| 05/25/2010 | US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor |
| 05/25/2010 | US7723360 Alkyl-and piperidine-substituted benzimidazole derivatives |
| 05/25/2010 | US7723359 such as 2-{5-Bromo-2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-4-methyl-1H-benzoimidazole, used in leukocyte recruitment inhibition, modulation of histamine H4 receptors and in treating conditions such as inflammation |
| 05/25/2010 | US7723358 such as hypertriglyceridaemia, hypercholesterolemia, dyslipidaemia, or obesity; 6-methyl-N-[3-[[1-(methylsulfonyl)-4-piperidinyl]oxy]phenyl]-4'-(trifluoro-methoxy) [1,1'-biphenyl]-2-carboxamide |
| 05/25/2010 | US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus |
| 05/25/2010 | US7723356 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 05/25/2010 | US7723355 7,8-dihydro-1,6-naphthyridin-5(6H)-ones and related bicyclic compounds as inhibitors of dipeptidyl peptidase IV and methods |
| 05/25/2010 | US7723352 Isoquinolinone potassium channel inhibitors |
| 05/25/2010 | US7723351 A four arm-polyethylene glycol-7-ethyl-10-hydroxycamptothecin conjugate, prodrugs of (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; anticarcinogenic agents |
| 05/25/2010 | US7723350 (1S)-2-(6-chloro-1,2-dihydro-1'H-spiro[indole-3,4'-piperidin]-1'-yl)-1-{1-[(2E)-3-(3,5-difluorophenyl)-2-propenoyl]-4-piperidinyl}ethanol; gene overexpression |
| 05/25/2010 | US7723349 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions |
| 05/25/2010 | US7723348 Phosphodiesterase 4 inhibitors |
| 05/25/2010 | US7723347 Substituted phenylamino-pyrimidines |
| 05/25/2010 | US7723346 for treatment of focal distonia, tremors, and parkinson's disease; administering sodium salt of 5,5-diphenyl barbituric acid |
| 05/25/2010 | US7723345 Multicyclic amino acid derivatives and methods of their use |
| 05/25/2010 | US7723344 Dipeptidyl peptidase inhibitors |
| 05/25/2010 | US7723343 novel triazolopyrimidine derivatives like 7-(2-(4-(2,5-Difluorophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine; to treat central nervous system disorders like depression, Parkinson's disease; senile dementia; psychoses etc. |
| 05/25/2010 | US7723342 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 05/25/2010 | US7723340 mitogen-activated protein kinase 8 inhibitors, used for treating or preventing cancer, cardiovascular diseases, renal diseases, autoimmune disorders, inflammatory disorders, vision defects, ischemia-reperfusion injuries, pain and hypertension |
| 05/25/2010 | US7723339 signal transduction inhibitor is a PDGF receptor tyrosine kinase inhibitor or an active ingredient which decreases the activity of the epidermal growth factor; antiproliferative agent |
| 05/25/2010 | US7723338 Crystalline forms of 1-benzoyl-4-[2-[4,7-dimethoxy-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 05/25/2010 | US7723337 3-cinnolinecarboxamide derivatives and their use for treating cancer |
| 05/25/2010 | US7723336 Fused heterocyclic compounds useful as kinase modulators |
| 05/25/2010 | US7723335 Triazine compounds and their use in forming multidimensional libraries for affinity chromatography |
| 05/25/2010 | US7723334 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/25/2010 | US7723333 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 05/25/2010 | US7723332 Aryl sulfonamides useful for modulation of the progesterone receptor |
| 05/25/2010 | US7723331 Thienopyrimidine compounds and uses thereof |
| 05/25/2010 | US7723330 Heterobicyclic pyrazole compounds and methods of use |
| 05/25/2010 | US7723329 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/25/2010 | US7723328 relieving or causing regression of Alzheimer's disease comprising administering compounds having binding specificity for a p75NTR receptor molecule to treat neurodegenerative disorders |
| 05/25/2010 | US7723327 Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
| 05/25/2010 | US7723326 Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 05/25/2010 | US7723325 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors |
| 05/25/2010 | US7723324 Treating anxiety and insomnia; drugs facilitate the inhibitory action of the neurotransmitter GABA; 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-1-thiophen-2-yl-ethanone for example |
| 05/25/2010 | US7723323 fused 1,2,4-triazoles for modulating the activity of 11 beta -hydroxysteroid dehydrogenase type 1 (11 beta HSD1) and the use of these compounds as pharmaceutical compositions has been described. Also a novel class of fused 1,2,4-triazoles, their use in therapy, pharmaceutical compositions |
| 05/25/2010 | US7723322 that can trap isotopic fluorine so that when the biological molecule accumulates in the desired type of cell, the isotopic fluorine is imaged by PET scan |
| 05/25/2010 | US7723321 such as 4-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxyl]-N,N,2-trimethyl-1H-benzimidazole -6-carboxamide, used as acid pump antagonists for the treatment of gastrointestinal disorders |
| 05/25/2010 | US7723320 Use of estrogen compounds to increase libido in women |
| 05/25/2010 | US7723319 1-[(6-amino-9H-purin-9-yl)methyl]cyclopropyl}oxy)methylphosphonic acid; hepatitis virus |
| 05/25/2010 | US7723318 organometallic polymers containing thietane groups, used as raw materials for resins having high transparency, good heat resistance and mechanical strength required for optical components such as plastic lenses |
| 05/25/2010 | US7723316 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 05/25/2010 | US7723314 Methods and compositions for treating pachyonychia congenita |
| 05/25/2010 | US7723312 heat shock protein 27 inhibitors; RNA interference; nuclease resistance |
| 05/25/2010 | US7723310 increasing patient compliance in treatment of hepatitis-C virus infection |
| 05/25/2010 | US7723309 Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| 05/25/2010 | US7723306 such as glucosyl and maltosyl sucrose; storage stability |
| 05/25/2010 | US7723305 Abuse-resistant amphetamine prodrugs |
| 05/25/2010 | US7723296 Coupling monosaccharide into glycoprotein; oxidation; increasing therapeutic efficiency |
| 05/25/2010 | US7723292 Detection and treatment of neoplasia; human C3 convertase from snake venom; C3convertase inhibitors from animal serum; kits; ACP/ANDS (Alternative Complement Pathway/Against Neoplasm Defending System) |
| 05/25/2010 | US7723080 Murine α (1,3) fucosyltransferase Fuc-TVII, DNA encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such DNA, and cells containing such a plasmid |
| 05/25/2010 | US7723075 Methods of screening for TRPM5 modulators |
| 05/25/2010 | US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 05/25/2010 | US7723035 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells |
| 05/25/2010 | US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders |
| 05/25/2010 | US7723021 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases |
| 05/25/2010 | US7723020 Use of azetidinone compounds |
| 05/25/2010 | US7723018 Identifying compounds which inhibit cell cycle progression for use in treating cell proliferative disorders agents for treat; antiproliferative/antitumor agents |
| 05/25/2010 | US7722903 Modulation of inflammation by hops fractions and derivatives |
| 05/25/2010 | US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells |
| 05/25/2010 | US7722595 Method and device for controlling drug pharmacokinetics |
| 05/25/2010 | CA2672513C Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
| 05/25/2010 | CA2606843C Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones |
| 05/25/2010 | CA2593381C Processes for producing 7-isoindolinequinolonecarboxylic acid derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and compositions containing the same as active ingredient |
| 05/25/2010 | CA2584975C Drug and food or drink for improving pancreatic functions |
| 05/25/2010 | CA2581752C Device for delivering an anti-microbial composition |
| 05/25/2010 | CA2577589C Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation |
| 05/25/2010 | CA2528232C Novel nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin |
| 05/25/2010 | CA2522734C New polymorphs of olanzapine hydrochloride |
| 05/25/2010 | CA2508307C A method of preventing and/or treating asthma using parabromophenacyl bromide (pbpb) |
| 05/25/2010 | CA2503975C Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain |
| 05/25/2010 | CA2496723C New process for synthesizing ivrabradine and its pharmaceutically acceptable acid addition salts |
| 05/25/2010 | CA2493794C Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 05/25/2010 | CA2489337C Indole derivatives useful as histamine h3 antagonists |
| 05/25/2010 | CA2489136C Novel 3-(4-oxo-40-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/25/2010 | CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists |
| 05/25/2010 | CA2462922C Reverse-turn mimetics and method relating thereto |
| 05/25/2010 | CA2462746C Decontamination of surfaces contaminated with prion-infected material with oxidizing agent-based formulations |
| 05/25/2010 | CA2441352C Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 05/25/2010 | CA2439295C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 05/25/2010 | CA2434961C L-histidine in ophthalmic solutions |
| 05/25/2010 | CA2433128C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/25/2010 | CA2431761C Novel 2,3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient |
| 05/25/2010 | CA2426263C Nateglinide-containing preparation |
| 05/25/2010 | CA2421512C Cosmetic and pharmaceutical compositions and their use |
| 05/25/2010 | CA2415178C 9-substituted minocycline compounds |
| 05/25/2010 | CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors |
| 05/25/2010 | CA2402667C 6-oxygenated steroidal estrogens with aromatic a and b rings |
| 05/25/2010 | CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds |
| 05/25/2010 | CA2394471C External preparation for treating pruritus |
| 05/25/2010 | CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
| 05/25/2010 | CA2375923C Devices and compounds for treating arterial restenosis |
| 05/25/2010 | CA2375727C Cytofectin dimers and methods of use thereof |
| 05/25/2010 | CA2369232C Fused pyrazolyl compounds |